Bonnie Anderson

PinkDx is an early-stage women’s Healthcare company dedicated to building a leading enterprise bringing equitable care to women. Initially, the company is focused on the discovery and development of novel, new approaches to improve the journey millions of women navigate in getting answers to symptoms that are suspicious for cancer. PinkDx tests will improve patient outcomes, provide answers for physicians, and reduce the time and cost of care. The PinkDx co-founders are industry veterans with a passion for building a women’s health enterprise and for the opportunity to have impact for women all over the world. The Company has raised a $40 million Series A from top investors.